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i 
Abstract 
 
Access to a diverse array of druglike organic molecules via efficient total synthesis is of critical 
importance for the exploration of new compounds of biological and medicinal interest.  In 
particular, any viable synthetic route to such molecules must incorporate precise control of 
stereochemistry as well as the ability to tune medicinally relevant parameters such as acidity, 
lipophilicity, and the incorporation of bioisosteres.  Synthesis of a bioisosteric analog of the 
opiate analgesic morphine was pursued using an intramolecular ylide-alkene cycloaddition as the 
key step which would establish the configuration of the six stereocenters of the molecule in a 
single operation.  The novel structure of the target analog should produce a compound with 
compelling biological activity from a brief, diversifiable synthesis. 
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1 
 
Introduction 
 
Opiate analgesic drugs such as the natural product morphine 1 represent a biologically potent and 
clinically important class of organic compounds.  The clinical usefulness of several morphine 
analogs such as butorphanol 2, morphinan 3, and benzomorphan 4 indicates that the chemical 
synthesis of morphine analogs represents a promising route for the discovery of biologically 
active organic materials. 
 
Of particular interest to our laboratory is the preparation of morphine analogs in which the 
catechol motif 5 present in morphine is replaced with bioisosteric1 benzoxazole groups 6 and 7 
and benzothiazole group 8.  Accordingly, synthetic targets 9, 10, and 11 are currently being 
pursued in our laboratory, with analog 9 being the subject of this study. 
 
N
O
O
OH
H
CO2Et
O
N
O
OH
H
CO2Et
109
N
S
H2N
O
OH
H
CO2Et
11
 
The complex, polycyclic structure of these analgesic analogs mandates a synthetic route 
displaying excellent regiochemical and stereochemical control.  To this end, the total synthesis of 
2 
analog 9 was pursued via a photoinitiated intramolecular ylide-alkene cycloaddition reaction 
developed in our laboratory, which allows for the construction of up to three rings and six chiral 
centers in a single experimental operation. 
 
3 
Background 
 
The basis for the synthesis of natural product analogs in this study lies in the heteroatom-directed 
photoarylation reaction of aryl vinyl ethers 12a and aryl vinyl sulfides 12b.  This reaction was 
originally developed as a means of facile synthetic access to dihydrofuran 14a and 
dihydrothiophene 14b systems.2 Chemical and spectroscopic evidence supports the intermediacy 
of carbonyl ylide 13a and thiocarbonyl ylide 13b intermediates in this conversion.3-5 
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The synthetic utility of such ylide systems for cycloaddition processes is widely recognized, and 
several methods for their generation have been reported.6-8 Nevertheless, the heteroatom-directed 
photoarylation reaction has received relatively little attention in the literature as a strategy for the 
formation of these ylides.  Our laboratory has investigated the attachment of a pendant alkene to 
the photoarylation precursor that may react with the resulting ylide intermediate via an 
intramolecular [3+2] cycloaddition process. This concept is exemplified by the formation of 
generalized ylide 16 from precursor 15 to yield photoproducts 17a or 17b, depending on the 
length of the pendant alkene chain. 
 
4 
This strategy of photoarylation followed by intramolecular cycloaddition was viewed as a 
potentially rapid and powerful method for constructing multicyclic organic scaffolds. 
 
Previous studies in our laboratory have established several factors controlling product formation 
in the photoinitiated intramolecular ylide-alkene cycloaddition.  For example, low-temperature 
irradiation of a solution of 18 in toluene provided product 19, which is consistent with ylide 
formation and subsequent hydrogen shift.9 
 
In contrast, high-temperature irradiation of 18 in toluene resulted in formation of unexpected 
intramolecular addition product 19 as a mixture of diastereomers 19a and 19b.9 
 
Control experiments indicated that both light and heat are required for the formation of 
intramolecular addition products such as 19, suggesting that photochemical ylide formation is 
followed by a thermally induced intramolecular process.  While valuable for determining the 
thermal requirement for such reactions, these studies of aryl vinyl sulfides failed to produce the 
desired [3+2] addition product, which motivated subsequent studies of aryl vinyl ether systems. 
5 
The temperature dependence of the ylide-alkene addition reaction was found to extend to aryl 
vinyl ethers, although the overall reactivity of such ether systems is generally quite different.  
For example, when aryl vinyl ether 20 was subjected to irradiation in toluene at room 
temperature, the major product 21 was consistent with photocyclization followed by hydrogen 
shift, and a minor product 22 was also formed that was analogous to aryl vinyl sulfide addition 
product 19.  At this temperature, the desired [3+2] addition product was not observed.10 
 
However, at high temperature irradiation of 20 furnishes the desired [3+2] cycloaddition product 
23 as the major product in addition to addition product 24.  Thus, while aryl vinyl ether systems 
preserve the requirements for heat and light observed with aryl vinyl sulfides, changing the 
heteroatom to oxygen alters the reactivity to allow the formation of the desired [3+2] adduct, 
which was never observed for the sulfur analogs.11 
 
Additionally, it was observed that substitution of the pendant alkene with electron-withdrawing 
groups greatly favors formation of the [3+2] cycloaddition product.  This is evidenced by the 
irradiation of aryl vinyl ether 25, which effected the high-yield preparation of [3+2] addition 
6 
product 26 even at room temperature, with trace amounts of addition product 27 occasionally 
observed.11 
O
O
h , toluene
25° C
O
CO2Et
H
OO
OH +
27
(trace)
26
85-87%
EtO2C
CO2Et
25
 
Having studied the reactivity of naphthyl vinyl ethers, the potential for similar reactions of 
phenyl vinyl ethers was explored.  Unfortunately, irradiation of phenyl-substituted precursor 28 
at a variety of temperatures furnished only ring-closed product 29 and none of expected 
intramolecular addition product 30, nor of a [3+2] cycloaddition product.11 
 
The difference in reactivity for such phenyl-substituted systems could be rationalized by the loss 
of aromaticity upon formation of the ylide, reducing the resonance stabilization of the 
intermediate relative to the corresponding naphthyl system.  Because they retain aromaticity to 
some extent during ylide formation, bicyclic aryl groups would be expected to favor 
intramolecular ylide-alkene cycloaddition. 
 
Given these precedents, we expected that synthetic target 9 could be prepared from 
photoprecursor 31 via ylide intermediate 32. 
7 
 
Success with heterocyclic aromatic systems would further extend the utility of our methodology 
in the synthesis of natural product analogs.  For example, the benzoxazole group, in addition to 
its intended use in this study as a bioisosteric replacement for a catechol motif, could be 
hydrolyzed to reveal a disubstituted aromatic ring with additional potential for interesting 
reactivity and biological activity. 
 
The preparation of 31 is illustrated by the following synthesis, which is representative of many 
photoprecursor syntheses performed in our laboratory. 
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The aromatic alcohol 2-methylbenzo[d]oxazol-5-ol 37 required for this synthesis is not 
commercially available and was obtained synthetically.  Several methods for the generation of 
benzoxazole systems are available, and the Beckmann rearrangement of o-acylphenol oximes 
was selected as an appropriate and convenient approach to the desired hydroxy-substituted 
benzoxazole.12 Accordingly, it was expected that 37 could be prepared by conversion of 40 to the 
corresponding oxime 41 followed by subsequent cyclization to yield 37. 
9 
 
Synthesis of the desired photoprecursor in this manner should provide an efficient route to 
morphine analog 9 via intramolecular ylide-alkene cycloaddition, and, further, could exhibit 
broad utility in natural products synthesis. 
10 
Results and Discussion 
 
3-ethoxycyclohex-2-enone 33 was prepared from 1,3-cyclohexanedione 34 as shown.13  
Subsequent Grignard reaction of 34 with in situ prepared 4-bromomagnesium-1-butene afforded 
35 in 73% yield, which after epoxidation to 36 (59% yield) completed the first branch of the 
convergent synthesis of photoprecursor 31.9 
 
Additionally, the synthesis of aromatic alcohol 37 was achieved to complete the second branch 
of the synthesis. Acetophenone derivative 40 was cleanly converted to oxime 41 as shown (87% 
yield),14 which in turn was successfully subjected to conditions for Beckmann rearrangement to 
benzoxazole 37 in 65% yield.12  Although such benzoxazoles reportedly precipitate from 
aqueous solution, precipitation of 37 was not observed. Extraction with ethyl acetate proved a 
superior method for its isolation, with a single recrystallization from acetonitrile providing a 
convenient purification method. 
 
11 
Coupling of 36 with benzoxazole 37 via nucleophilic epoxide opening, followed by elimination, 
was subsequently achieved. A preliminary run at room temperature with a catalytic quantity of 
KH indeed furnished coupled product 38, as indicated by LC/MS analysis of the reaction 
mixture.  However, the rate of product formation under those conditions was impractically slow, 
due to the modest nucleophilicity of the hydroxyl oxygen atom of 37, and the reaction was 
incomplete after 5 days.  The reaction is greatly facilitated by heat, as well as by the addition of 
N,N’-dimethylpropyleneurea (DMPU), which is notable for its ability to facilitate nucleophilic 
substitutions.15 Under these conditions, the reaction was complete in 48 hours, with coupled 
product 38 as the major product, which was successfully purified by flash chromatography on 
silica gel. 
 
While the well-established conditions above remain the most reliable method to achieve the 
synthesis of coupled aryl vinyl ethers such as 38, the reaction was also attempted using a 
microwave reactor.16 In a pilot study, the reaction mixture was irradiated for two hours at 110 °C 
in fixed-temperature mode.  Although the irradiation time and temperature have not been 
optimized, 38 was indeed observed by 1H NMR analysis as a product of the microwave-assisted 
coupling reaction. 
 
12 
 
Modification of the pendant alkene group of 38 via ozonolysis, followed by Wittig addition, will 
complete the synthesis of photoprecursor 31. 
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Upon irradiation in toluene at reflux, photoprecursor 31 is expected to furnish photoproduct 9 via 
ylide formation and subsequent [3+2] cycloaddition.  This preparation of 9 is notable for its 
brevity—with a longest linear sequence of 7 steps, this scheme will establish a multicyclic 
scaffold with precise stereocontrol in a remarkably brief synthesis. 
O
N
O
OH
H
CO2Et
O
OEtO2C
O
N
931
h , toluene
110 °C
 
13 
Experimental 
General Methods 
 
1H NMR spectra were recorded on a Bruker AVANCE III 500 (500 MHz) NMR spectrometer. 
Chemical shifts are reported in ppm (δ) relative to tetramethylsilane at 0.00. 13C NMR spectra 
were recorded at 125.72 MHz.  Infrared spectra (IR) were recorded on a Bruker Vertex 70 
Infrared Spectrometer equipped with an ATR accessory, scanning from 4000 to 650 cm-1 over 16 
scans.  Analytical thin-layer chromatography was performed on precoated silica gel plates (0.25 
mm thickness) with a 254 nm fluorescent indicator and was visualized under ultraviolet light 
and/or with a p-anisaldehyde stain.  Flash chromatography was performed on Thompson Single 
StEP pre-packed silica gel columns using an AnaLogix IntelliFlash 280 automated 
chromatography system. LC/MS data were obtained on an Agilent Technologies 6130 
Quadrupole LC/MS using an SB-C18 Rapid Resolution 3.5 µm, 2.1x30 mm Zorbax HRLC 
cartridge column.  Microwave-assisted reactions were performed using an Emrys Optimizer 
automated microwave synthesizer. 
14 
3-ethoxycyclohex-2-enone 
 
(33, DJS-I-001, DJS-I-002, DJS-I-008) 
O
O O
OEt
EtOH, p-TsOH
Toluene
33 34  
To a 2-L three-neck flask fitted with a water-cooled reflux condenser and Dean Stark trap was 
added 1,3-cyclohexanedione 33 (57.54 g, 0.51 mmol) and ethanol (100 mL).  To this solution 
was added toluene (900 mL) and p-toluenesulfonic acid monohydrate (2.32 g).  The resulting 
solution was refluxed for 3 h with periodic removal of the distillate, and subsequently was 
concentrated under reduced pressure.  The residue was taken up in toluene and washed with 10% 
aqueous NaOH solution saturated with NaCl (4 x 100 mL).  The organic layer was washed with 
water until the aqueous washings were neutral, washed with brine, and dried (MgSO4).  The 
product was concentrated under reduced pressure and subsequently distilled under reduced 
pressure to furnish 34 as a light-yellow oil (25.49 g, 34%): bp 76-78 °C (1 mm Hg); 1H NMR 
(CDCl3, 500 MHz) δ 1.35 (t, 3 H, J = 7 Hz), 1.97 (m, 2 H), 2.33 (t, 2H, J = 6 Hz), 2.39 (t, 2H, J 
= 6 Hz), 3.89 (q, 2 H, J = 7 Hz), 5.33 (s, 1 H). 
15 
3-(3-butenyl)-2-cyclohexenone  
 
(35, DJS-I-007, DJS-I-009, DJS-I-011) 
 
 
In a dry flask under nitrogen was added magnesium (0.140 g, 5.76 mmol) in dry THF (1 mL).  4-
Bromo-1-butene (0.386 mL, 3.80 mmol) was added slowly with gentle heating.  A vigorous 
exothermic reaction was observed.  An additional portion of dry THF (0.9 mL) was added.  The 
mixture was stirred until the exothermic reaction had subsided, followed by an additional 30 min 
at room temperature.  3-ethoxycyclohex-2-enone 34 (0.519 mL, 3.57 mmol) was added 
dropwise, followed by an additional portion of dry THF (1.8 mL). The mixture was stirred at 
room temperature for 18 h.  The resulting solution was partitioned between dichloromethane and 
a saturated aqueous solution of ammonium chloride (10 mL).  The organic layer was 
concentrated under reduced pressure.  The residue was stirred for 1 h in a solution of HCl (1 M, 
1 mL) and ethanol (2.5 mL). The solution was neutralized with saturated aqueous sodium 
bicarbonate and concentrated under reduced pressure.  The residue was taken up in 
dichloromethane, washed with water, brine, and dried (MgSO4).  The sample was concentrated 
under reduced pressure to yield 35 as an orange oil, (0.389 g, 73%): 1H NMR (CDCl3, 500 MHz) 
δ 1.99 (m, 2 H), 2.25-2.33 (m, 6 H), 2.36 (t, 2 H, J = 6 Hz), 5.00 (d, 1 H, J = 10 Hz), 5.05 (d, 1H, 
J = 17 Hz), 5.79 (m, 1H), 5.88 (s, 1 H). 
16 
6-(3-butenyl)-7-oxabicyclo[4.1.0]heptan-2-one  
 
(36, DJS-I-013, DJS-I-014, DJS-I-016) 
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35 36  
Aqueous hydrogen peroxide (1.567 mL, 6.66 mmol) was added to a solution of 3-(3-butenyl)-2-
cyclohexenone 35 (1.00 g, 6.66 mmol) in methanol (6.3 mL). The mixture was cooled to 0 °C, 
and a solution of sodium hydroxide (0.57 mL, 3.43 mmol) was added slowly. The mixture was 
stirred at room temperature for 2 h, after which solvent was removed under reduced pressure.  
The product was partitioned between dichloromethane and water, and the organic phase was 
washed with water, brine, and dried (MgSO4).  Removal of solvent furnished 36 as a colorless 
oil (0.653 g, 59%): bp 100 °C (5 mm Hg); 1H NMR (CDCl3, 500 MHz) δ 1.22-1.58 (m, 9H), 
2.45 (d, 1H, J = 18 Hz), 3.04 (s, 1H), 4.95 (d, 1H, J = 10 Hz), 5.00 (d, 1H, J = 17 Hz), 5.75 (m, 
1H). 
 
 
17 
(E)-1-(2,5-dihydroxyphenyl)ethanone oxime  
 
(41, DJS-I-018) 
 
 
To a solution of hydroxylamine hydrochloride (1.53 mL, 36.8 mmol) and sodium acetate (1.779 
g, 21.69 mmol) in water (4 mL) was added a solution of 1-(2,5-dihydroxyphenyl)ethanone 40 
(1.00 g, 6.57 mmol) in boiling water (40 mL). The resulting solution was heated at reflux for 2 h 
and extracted with ethyl acetate. The organic phase was washed with water, brine, and dried 
(MgSO4).  Solvent was removed under reduced pressure to furnish 41 (0.954 g, 87%) as a 
crystalline, off-white solid: 1H NMR (DMSO-d6, 500 MHz) δ 2.20 (s, 3H), 6.68 (s, 2H) 6.85 (d, 
1H, J = 2 Hz), 8.91 (s, 1H), 10.85 (s, 1H), 11.48 (s, 1H). 
 
18 
2-methylbenzo[d]oxazol-5-ol 
(37, DJS-I-010, DJS-I-012, DJS-I-015, DJS-I-017, DJS-I-023) 
O
NHO1. POCl3, DMA, 0°C
2. CH3COONa, H2O
37
N
OH
OH
HO
41  
(E)-1-(2,5-dihydroxyphenyl)ethanone oxime 41 (4.20 g, 25.1 mmol) was dissolved in dry N,N-
dimethylacetamide (5.0 mL) and dry acetonitrile (15.0 mL). The solution was cooled to 0 °C, 
and phosphorus oxychloride (2.42 mL, 26.0 mmol) was added during 3 min. The solution was 
stirred at room temperature for 60 min, after which a solution of ice/water (200 mL) containing 
sodium acetate (6.00 g) was added. The product was extracted with ethyl acetate, and the 
combined organic phases were washed with water, brine, and dried (MgSO4).  The resulting 
solution was concentrated under reduced pressure to furnish 37 as a dark brown solid (crude 
yield: 2.438 g, 65%).  The crude product was recrystallized from acetonitrile to furnish the 
analytical sample (isolated yield: 1.843 g, 49%): 1H NMR (DMSO-d6, 500 MHz) δ 2.54 (s, 3H), 
6.75 (dd, 1H, J = 9 and 2 Hz), 6.95 (d, 1H, J = 2 Hz), 7.41 (d, 1H, J = 9 Hz), 9.39 (s, 1H). 
 
19 
3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone  
 
(38, DJS-I-019, DJS-I-020, DJS-I-021, DJS-I-024, DJS-I-025) 
 
 
In a dry flask under nitrogen, 2-methylbenzo[d]oxazol-5-ol 37 (0.179 g, 1.203 mmol) was 
dissolved in dry THF (3 mL). A suspension of potassium hydride (30% in mineral oil, 0.074 g, 
0.568 mmol) in THF (2 mL) was added.  After 5 min, a solution of 6-(3-butenyl)-7-
oxabicyclo[4.1.0]heptan-2-one 36 (0.200 g, 1.203 mmol) in dry THF (2 mL) was added. DMPU 
(0.19 mL, 1.600 mmol) was added and the mixture was heated at reflux for 48 h. Solvent was 
removed under reduced pressure, and the residue was partitioned between diethyl ether and 
water.  The organic phase was washed with several portions of water, washed with brine, and 
dried (MgSO4).  Solvent was removed under reduced pressure to yield the crude product (0.260 
g, 73%), which was purified by flash chromatography on silica gel (hexanes-ethyl acetate (3:2)) 
to furnish 38 (0.110 g, 30.7 %): IR 2943, 1681, 1576, 1472, 1272, 1150, 923, 846 cm-1; 1H NMR 
(CDCl3, 500 MHz) δ 2.07 (m, 2H), 2.23 (q, 2H, J = 7 Hz), 2.40 (t, 2H, J = 7 Hz), 2.50-2.56 (m, 4 
H), 2.59 (s, 3H), 4.96 (d, 1H, J = 10 Hz), 5.00 (dd, 1H, J = 17 and 2 Hz), 5.73 (m, 1H), 6.93 (dd, 
1H, J = 9 and 2 Hz), 7.01 (d, 1H, J = 2 Hz), 7.33 (d, 1H, J = 9 Hz); 13C NMR (CDCl3, 125.72 
MHz) δ 14.6 (CH3), 22.2 (CH2), 29.6 (CH2), 30.8 (CH2), 31.2 (CH2), 38.5 (CH2), 104.3 (CH),
110.3 (CH), 112.8 (CH), 115.6 (CH
 
2), 137.1 (CH), 142.2 (C), 144.5 (C), 146.3 (C), 151.6 (C), 
155.0 (C), 164.8 (C), 193.0 (C=O); LC/MS (ESI/APCI) m/z 298.2 (MH+). 
20 
Spectral Data 
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Figure 1: 1H NMR Spectrum of 3-ethoxycyclohex-2-enone (34)  
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Figure 2: 1H NMR Spectrum of 3-(3-Butenyl)-2-cyclohexenone (35)  
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Figure 3: 1H NMR Spectrum of 6-(3-butenyl)-7-oxabicyclo[4.1.0]heptan-2-one (36)  
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Figure 4: 1H NMR Spectrum of (E)-1-(2,5-dihydroxyphenyl)ethanone oxime (41)  
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Figure 5: 1H NMR Spectrum of 2-methylbenzo[d]oxazol-5-ol (37)  
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Figure 6: 1H NMR Spectrum of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone 
(38) 
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Figure 7: 13C NMR Spectrum of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone 
(38) 
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Figure 8: DEPT-90 Spectrum of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone 
(38) 
28 
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Figure 9: DEPT-135 Spectrum of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone 
(38) 
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Figure 10: COSY Spectrum of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone 
(38) 
30 
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Figure 11: TOCSY Spectrum of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone 
(38) 
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Figure 12: HMBC Spectrum of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone 
(38) 
 
32 
 
O
O
38
ON
Figure 13: Infrared Spectrum of 3-(but-3-enyl)-2-(2-methylbenzo[d]oxazol-5-yloxy)cyclohex-2-enone 
(38) 
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